Epidemiology of osteochimionecrosis of the jaws in France, update of data since 2015 - 29/09/22
Doi : 10.1016/j.jormas.2021.12.015
Q Legendre c, ⁎ 
, Jl Faillie b, P Lapeyrie c, P Tramini d, E Maladiere a, JH Torres d, B Lallemant e
, Jl Faillie b, P Lapeyrie c, P Tramini d, E Maladiere a, JH Torres d, B Lallemant e a Maxillofacial Surgery Department, Hospital Center, Perpignan, France, 20 avenue du Languedoc, 66000 Perpignan, France
b Medical Pharmacology and Toxicology Department, University Hospital, Montpellier, France, 191 Avenue du Doyen Gaston Giraud, 34295 Montpellier, France
c Oral Surgery Department, University Hospital, Nimes, France, 4Rue du Professeur Robert Debré, 30900 Nimes, France
d Dental Care, Teaching and Research Centre, University Hospital, 549 Avenue du Professeur Jean Louis Viala, 34295 Montpellier, France
e Otolaryngology, Head and Neck Surgery, University Hospital, 4 Rue du Professeur Robert Debré, 30900 Nimes, France
⁎Corresponding author.
Highlights |
• | The incidence of osteochimionecrosis of the jaws appears to be increasing. |
• | Since 2015 bisphosphonates are not any longer the main causing drugs. |
• | Since 2015 Denosumab became the main causing drug. |
• | More than one third of the cases were due to non-oncological drug prescriptions. |
Keywords : Osteochimionecrosis, Osteonecrosis of the jaw, Denosumab, Bisphosphonates, Pharmacovigilance, Adverse drug reaction
Plan
© 2021
Elsevier Masson SAS. Tous droits réservés.
Vol 123 - N° 5
P. e448-e453 - octobre 2022 Retour au numéro
Article précédent
- A retrospective cohort study on predictors associated with skull base invasion of maxillary ameloblastomas
- Poramate Pitak-Arnnop, Keskanya Subbalekha, Nattapong Sirintawat, Jean-Paul Meningaud, Chatpong Tangmanee, Prim Auychai, Andreas Neff
- Early-onset osteoradionecrosis following adjuvant volumetric-modulated arc therapy to an osteocutaneous free fibula flap with customized titanium plate
- David A. Daar, David J. Byun, Karl Spuhler, Lavinia Anzai, Lukasz Witek, David Barbee, Kenneth S. Hu, Jamie P. Levine, Adam S. Jacobson
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?